The future of clinical trials for Alzheimer's disease. A blood-based biomarker perspective

Nicholas Cullen

Research output: Thesis › Doctoral Thesis (compilation)

4 Downloads (Pure)

2 Article

2 results

2021
Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
Cullen, N. C., Leuzy, A., Janelidze, S., Palmqvist, S., Svenningsson, A. L., Stomrud, E., Dage, J. L., Mattsson-Carlgren, N. & Hansson, O., 2021 Dec, In: Nature Communications. 12, 1, 3555.
Research output: Contribution to journal › Article › peer-review

Open Access
2020
Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
Cullen, N. C., Zetterberg, H., Insel, P. S., Olsson, B., Andreasson, U., Blennow, K., Hansson, O. & Mattsson-Carlgren, N., 2020 Sep, In: Annals of Clinical and Translational Neurology. 7, 9, p. 1661-1673 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access